3i, LP 13D and 13G filings for CNBX Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 5:07 pm Purchase | 2026-03-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 124,946,375 9.900% | 41,350,834 (+49.47%) | Filing |
| 2026-02-05 4:07 pm Purchase | 2025-12-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 83,595,541 9.900% | 2,730,297 (+3.38%) | Filing |
| 2025-11-10 4:58 pm Purchase | 2025-09-30 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 80,865,244 9.900% | 67,292,128 (+495.78%) | Filing |
| 2025-08-13 4:05 pm Purchase | 2025-06-30 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 13,573,116 9.900% | 10,153,028 (+296.86%) | Filing |
| 2025-05-13 9:06 pm Purchase | 2025-03-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 3,420,088 9.900% | 7,531 (+0.22%) | Filing |
| 2025-02-13 4:06 pm Purchase | 2024-12-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 3,412,557 9.900% | 72,129 (+2.16%) | Filing |
| 2024-11-14 4:12 pm Purchase | 2024-09-30 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 3,340,428 9.900% | 20,637 (+0.62%) | Filing |
| 2024-02-13 4:27 pm Purchase | 2023-12-31 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 3,319,791 9.900% | 3,080,811 (+1289.15%) | Filing |
| 2023-03-06 5:03 pm Purchase | 2022-11-11 | 13G | CNBX PHARMACEUTICALS INC CNBX | 3i, LP | 238,980 9.980% | 238,980 (New Position) | Filing |